rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
14
|
pubmed:dateCreated |
2003-11-17
|
pubmed:abstractText |
The purpose of this study was to investigate the expression and prognostic significance of CD44 in epithelial ovarian cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1078-0432
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5318-24
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14614016-Adenocarcinoma, Mucinous,
pubmed-meshheading:14614016-Antigens, CD44,
pubmed-meshheading:14614016-Carcinoma, Endometrioid,
pubmed-meshheading:14614016-Cell Differentiation,
pubmed-meshheading:14614016-Chemotherapy, Adjuvant,
pubmed-meshheading:14614016-Cystadenocarcinoma, Serous,
pubmed-meshheading:14614016-Epithelium,
pubmed-meshheading:14614016-Female,
pubmed-meshheading:14614016-Finland,
pubmed-meshheading:14614016-Humans,
pubmed-meshheading:14614016-Hyaluronic Acid,
pubmed-meshheading:14614016-Middle Aged,
pubmed-meshheading:14614016-Neoplasm Recurrence, Local,
pubmed-meshheading:14614016-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:14614016-Ovarian Neoplasms,
pubmed-meshheading:14614016-Prognosis,
pubmed-meshheading:14614016-Stromal Cells,
pubmed-meshheading:14614016-Survival Rate,
pubmed-meshheading:14614016-Tumor Markers, Biological
|
pubmed:year |
2003
|
pubmed:articleTitle |
CD44 expression indicates favorable prognosis in epithelial ovarian cancer.
|
pubmed:affiliation |
Department of Pathology and Forensic Medicine, University of Kuopio and Kuopio University Hospital, Finland.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|